Strong effects of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs

Nature Communications

Volumn 5, Issue , 2014, Pages

  Enroth, Stefan ^a   Johansson, Åsa ^a,b   Enroth, Sofia Bosdotter ^c   Gyllensten, Ulf ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA CLINICAL RESEARCH CENTER   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER; BIOLOGICAL MARKER;

BIOMARKER; GENETIC VARIATION; GENOME; HERITABILITY; LIFESTYLE; PROTEIN;

ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; FEMALE; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; HEREDITY; HUMAN; INFLAMMATION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROTEIN ANALYSIS; BLOOD; EPIDEMIOLOGY; GENETICS; METABOLISM; REFERENCE VALUE; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN;

BIOMARKERS; BIOMARKERS, TUMOR; COHORT STUDIES; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFLAMMATION; LIFE STYLE; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE VALUES; SWEDEN;

EID: 84907323440     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms5684     Document Type: Article

References (62)

1. Prensner, J. R., Rubin, M. A., Wei, J. T. & Chinnaiyan, A. M. Beyond PSA: the next generation of prostate cancer biomarkers. Sci. Trans. Med. 4, 127rv123 (2012).
2. Scholler, N. & Urban, N. CA125 in ovarian cancer. Biomark. Med. 1, 513-523 (2007).
3. Yue, C. et al. The effects of adalimumab and methotrexate treatment on peripheral Th17 cells and IL-17/IL-6 secretion in rheumatoid arthritis patients. Rheumatol. Int. 30, 1553-1557 (2010).
4. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011).
5. Cao, Y., DePinho, R. A., Ernst, M. & Vousden, K. Cancer research: past, present and future. Nat. Rev. Cancer 11, 749-754 (2011).
6. Brooks, J. D. Translational genomics: The challenge of developing cancer biomarkers. Genome Res. 22, 183-187 (2012).
7. Schwanhausser, B. et al. Global quantification of mammalian gene expression control. Nature 473, 337-342 (2011).
8. Johansson, A. et al. Identification of genetic variants influencing the human plasma proteome. Proc. Natl Acad. Sci. USA 110, 4673-4678 (2013).
9. Lundberg, M., Eriksson, A., Tran, B., Assarsson, E. & Fredriksson, S. Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood. Nucleic Acids Res. 39, e102 (2011).
10. Assarsson, E. et al. Homogenous 96-Plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS ONE 9, e95192 (2014).
11. Melzer, D. et al. A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet. 4, e1000072 (2008).
12. Gao, Y. C., Yuan, Z. B., Yang, Y. D. & Lu, H. K. Effect of freeze-thaw cycles on serum measurements of AFP, CEA, CA125 and CA19-9. Scand. J. Clin. Lab. Invest. 67, 741-747 (2007).
13. Besingi, W. & Johansson, A. Smoke related DNA methylation changes in the etiology of human disease. Hum. Mol. Genet. 23, 2290-2297 (2014).
14. Kiechl, S. et al. Association of variation at the ABO locus with circulating levels of soluble intercellular adhesion molecule-1, soluble P-selectin, and soluble E-selectin a meta-analysis. Circ. Cardiovasc. Gene 4, 681-U436 (2011).
15. Qi, L. et al. Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes. Hum. Mol. Genet. 19, 1856-1862 (2010).
16. Feng, Y. et al. Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer. Anat. Rec. 293, 802-812 (2010).
17. Stacker, S. A., Achen, M. G., Jussila, L., Baldwin, M. E. & Alitalo, K. Lymphangiogenesis and cancer metastasis. Nat. Rev. Cancer. 2, 573-583 (2002). (Pubitemid 37328924)
18. Bolstad, N., Oijordsbakken, M., Nustad, K. & Bjerner, J. Human epididymis protein 4 reference limits and natural variation in a Nordic reference population. Tumour Biol. 33, 141-148 (2012).
19. Barbosa-Morais, N. L. et al. The evolutionary landscape of alternative splicing in vertebrate species. Science 338, 1587-1593 (2012).
20. Derrien, T. et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 22, 1775-1789 (2012).
21. Asmann, Y. W. et al. Detection of redundant fusion transcripts as biomarkers or disease-specific therapeutic targets in breast cancer. Cancer Res. 72, 1921-1928 (2012).
22. Fredrickson, B. L. et al. A functional genomic perspective on human well-being. Proc. Natl Acad. Sci. USA 110, 13684-13689 (2013).
23. Schadt, E. E. et al. Mapping the genetic architecture of gene expression in human liver. PLoS Biol. 6, e107 (2008).
24. Stranger, B. E. et al. Population genomics of human gene expression. Nat. Genet. 39, 1217-1224 (2007). (Pubitemid 47482691)
25. Damas, J. K. et al. Enhanced levels of CCL19 in patients with advanced acquired immune deficiency syndrome (AIDS). Clin. Exp. Immunol. 167, 492-498 (2012).
26. Pare, G. et al. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6, 578 women. PLoS Genet. 4, e1000118 (2008).
27. Antonelli, A. et al. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmun. Rev. 13, 272-280 (2014).
28. Antonelli, A. et al. High serum levels of CXC (CXCL10) and CC (CCL2) chemokines in untreated essential hypertension. Int. J. Immunopathol. Pharmacol. 25, 387-395 (2012).
29. WHO. Fact sheet No 297 (http://www.who.int/mediacentre/factsheets/fs297/ en/) (2013).
30. Boye, K. et al. EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer. Br. J. Cancer 107, 667-674 (2012).
31. Neurath, M. F. & Finotto, S. IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer. Cytokine Growth Factor Rev. 22, 83-89 (2011).
32. Rosman, Z., Shoenfeld, Y. & Zandman-Goddard, G. Biologic therapy for autoimmune diseases: an update. BMC Med. 11, 88 (2013).
33. Pers, Y. M. et al. Predictors of response and remission in a large cohort of rheumatoid arthritis patients treated with tocilizumab in clinical practice. Rheumatology 53, 76-84 (2014).
34. Antonelli, A. et al. Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists. J. Clin. Endocrinol. Metab. 91, 614-620 (2006). (Pubitemid 43236933)
35. Zhao, S. X. et al. Robust evidence for five new Graves' disease risk loci from a staged genome-wide association analysis. Hum. Mol. Genet. 22, 3347-3362 (2013).
36. Chu, X. et al. A genome-wide association study identifies two new risk loci for Graves' disease. Nat. Genet. 43, 897-901 (2011).
37. Gallup. GALLUP POLL SOCIAL SERIES: CONSUMPTION HABITS (http://www.gallup.com/poll/156833/one-five-adults-smoke-tied-time-low.aspx) (2012).
38. Marcus, C. S., Maxwell, G. L., Darcy, K. M., Hamilton, C. A. & McGuire, W. P. Current approaches and challenges in managing and monitoring treatment response in ovarian cancer. J. Cancer 5, 25-30 (2014).
39. Takayama, R. et al. Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinoma. J. Gastroenterol. 45, 52-59 (2010).
40. Lango Allen, H. et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467, 832-838 (2010).
41. Teslovich, T. M. et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707-713 (2010).
42. le Coutre, P. et al. In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor. J. Natl Cancer I 91, 163-168 (1999). (Pubitemid 29042694)
43. Chin, L., Andersen, J. N. & Futreal, P. A. Cancer genomics: from discovery science to personalized medicine. Nat. Med. 17, 297-303 (2011).
44. Johansson, A. et al. Common variants in the JAZF1 gene associated with height identified by linkage and genome-wide association analysis. Hum. Mol. Genet. 18, 373-380 (2009).
45. Igl, W., Johansson, A. & Gyllensten, U. The Northern Swedish Population Health Study (NSPHS)-a paradigmatic study in a rural population combining community health and basic research. Rural Remote Health 10, 1363 (2010).
46. Enroth, S., Dahlbom, I., Hansson, T., Johansson, A. & Gyllensten, U. Prevalence and sensitization of atopic allergy and coeliac disease in the Northern Sweden Population Health Study. Int. J. Circumpolar Health 72 (2013).
47. Igl, W. et al. Animal source food intake and association with blood cholesterol, glycerophospholipids and sphingolipids in a northern Swedish population. Int. J. Circumpolar. Health 72 (2013).
48. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 284, 3043-3045 (2000).
49. Mascalzoni, D. et al. Comparison of participant information and informed consent forms of five European studies in genetic isolated populations. Eur. J. Hum. Genet. 18, 296-302 (2010).
50. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575
51. Glodzik, D. et al. Inference of identity by descent in population isolates and optimal sequencing studies. Eur. J. Hum. Genet. 21, 1140-1145 (2013).
52. Genomes Project, C. et al. A map of human genome variation from populationscale sequencing. Nature 467, 1061-1073 (2010).
53. IMPUTE2 (https://mathgen.stats.ox.ac.uk/impute/impute-v2.html#reference) (2012).
54. Delaneau, O., Zagury, J. F. & Marchini, J. Improved whole-chromosome phasing for disease and population genetic studies. Nat. Methods 10, 5-6 (2013).
55. Howie, B., Fuchsberger, C., Stephens, M., Marchini, J. & Abecasis, G. R. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat. Genet. 44, 955-959 (2012).
56. Freeman, C. & Marchini, J. GTOOL (http://www.well.ox.ac.uk/Bcfreeman/ software/gwas/gtool.html) (2013).
57. Band, G. & Marchini, J. QCTOOL (http://www.well.ox.ac.uk/Bgav/qctool/ ) (2013).
58. Wolpin, B. M. et al. Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium. Cancer Epidemiol Biomark. Prevent. 19, 3140-3149 (2010).
59. R Develpment Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2012).
60. Krzywinski, M. et al. Circos: an information aesthetic for comparative genomics. Genome Res. 19, 1639-1645 (2009).
61. Aulchenko, Y. S., Ripke, S., Isaacs, A. & Van Duijn, C. M. GenABEL: an R library for genome-wide association analysis. Bioinformatics. 23, 1294-1296 (2007). (Pubitemid 47050548)
62. Chen, W. M. & Abecasis, G. R. Family-based association tests for genomewide association scans. Am. J. Hum. Genet. 81, 913-926 (2007). (Pubitemid 47580246)